Veterinary CRO Market Size and Outlook 2030

Report Description

Forecast Period	2026-2030
Market Size (2024)	USD 1.62 Billion
CAGR (2025-2030)	8.53%
Fastest Growing Segment	Clinical Trials
Largest Market	North America
Market Size (2030)	USD 2.65 Billion

Market Overview

The Global Veterinary CRO Market, valued at USD 1.62 Billion in 2024, is projected to experience a CAGR of 8.53% to reach USD 2.65 Billion by 2030. The Global Veterinary Contract Research Organization (CRO) market encompasses outsourced research and development services for animal health products, including pharmaceuticals, vaccines, and diagnostics, provided to pharmaceutical companies, biotechnology firms, and animal health organizations. Key market drivers include the increasing global pet population, rising animal health expenditure, and a greater prevalence of animal diseases necessitating advanced treatments. According to the American Pet Products Association, in 2024, veterinary care and products spending in the US is projected to reach $39.1 billion, underscoring the substantial investment in animal health.

A significant challenge impeding market expansion is the intricate and varying regulatory landscape across different regions. Navigating these complex regulatory frameworks for product development and approval demands specialized expertise and considerable resources, often leading to extended timelines and increased development costs for veterinary medicines.

Key Market Drivers

The global veterinary contract research organization market is notably influenced by growing research and development investments in veterinary pharmaceuticals and the strategic outsourcing by animal health pharmaceutical and biotechnology companies. Substantial financial commitments by industry leaders underpin the intensifying focus on innovative veterinary solutions. For example, according to Zoetis' 2023 Annual Report, the company incurred R&D expenses of $614 million in 2023, channeling funds into innovation across vaccines, biodevices, and digital solutions. Such dedicated investments are essential for advancing complex veterinary therapies and diagnostics, thereby generating a sustained demand for specialized research services. Concurrently, animal health pharmaceutical and biotechnology firms increasingly engage contract research organizations for their specialized expertise, advanced infrastructure, and capacity to accelerate product development cycles. This strategic shift enables companies to manage internal operational costs, access niche scientific capabilities, and navigate complex global regulatory landscapes more efficiently. A clear indication of this strategic outsourcing is that, according to PharmaLive, in October 2025, Boehringer Ingelheim plans to invest approximately $6.6 billion over the next five years to boost its manufacturing capabilities through partners across the United States. These interconnected drivers collectively propel the expansion and maturation of the global veterinary CRO market.

This dynamic environment fosters continuous innovation within animal health. The overall economic activity within the sector reflects a robust commitment to advancing animal well-being. According to a Business Wire press release, in February 2024, Zoetis reported total revenue of $8.5 billion for full year 2023, showcasing a significant portion of the global animal health sector's economic contribution. This substantial revenue figure underscores the continuous demand for and investment in animal health products and services, ultimately fueling the need for specialized contract research and development support.

Download Free Sample Report

Key Market Challenges

The intricate and varying regulatory landscape across different regions presents a significant impediment to the growth of the Global Veterinary Contract Research Organization (CRO) Market. Navigating these diverse and complex frameworks for veterinary product development and approval demands substantial specialized expertise and considerable financial resources. This complexity directly translates into extended development timelines, increasing the overall cost of bringing new animal health products to market. For instance, the extensive requirements for product validation across multiple species and geographical jurisdictions necessitate prolonged studies and exhaustive documentation, which ultimately impacts market velocity.

This challenge directly hampers market expansion by creating higher barriers to entry for smaller biotechnology firms and increasing the operational burden on larger pharmaceutical companies. The necessity for robust regulatory affairs teams and continuous adherence to evolving guidelines diverts resources that could otherwise be allocated to innovation or market expansion. According to HealthforAnimals, the global animal health sector invested an estimated $6.3 billion in research and development between November 2019 and 2023, highlighting the substantial financial commitments within the industry. The convoluted regulatory environment exacerbates these investments, making efficient and timely product launches more difficult for both sponsors and veterinary CROs.

Key Market Trends

Two significant trends shaping the Global Veterinary CRO Market are the increasing technological integration in veterinary clinical trials and a growing specialization in niche therapeutic areas and animal species. These distinct factors are advancing the market through enhanced research capabilities and targeted product development.

Technological Integration in Veterinary Clinical Trials
The global veterinary CRO market is increasingly driven by the adoption of advanced digital and data solutions, enhancing the efficiency and accuracy of R&D processes. This integration includes artificial intelligence, machine learning, and sophisticated data management platforms, enabling faster analysis of complex trial data and improved decision-making. For instance, Zoetis is investing in a new clinical data management system, scheduled to pilot in 2025, which will embed AI capabilities to improve data quality and streamline clinician data review. This technological evolution assists CROs by facilitating more precise and efficient clinical trials, thereby accelerating veterinary medicine development.

Specialization in Niche Therapeutic Areas and Animal Species
A prominent trend is the pronounced shift towards specialized research in specific therapeutic areas and animal species, driven by demand for targeted, effective treatments. This allows CROs to cultivate deep expertise and develop bespoke protocols for unique physiological needs. According to the North American Pet Health Insurance Association's 2024 report, Gross Written Premium for pet health insurance exceeded USD 3.9 billion in 2023, reflecting substantial financial commitment to animal well-being. This rising investment fosters demand for highly specialized research. For example, DVM360 reported in August 2024 that Elanco Animal Health invested $130 million to expand its biologics manufacturing facility, specifically supporting its monoclonal antibody platform and the Canine Parvovirus Monoclonal Antibody (CPMA). Such efforts highlight the industry's strategic pursuit of advanced, species-specific therapies.

Segmental Insights

The Clinical Trials segment is the fastest growing within the Global Veterinary CRO Market, primarily driven by increasing companion animal ownership and the resultant demand for advanced therapeutics. The rising global prevalence of animal diseases also necessitates substantial research and development for new veterinary pharmaceutical products. Pharmaceutical companies, therefore, increasingly outsource complex clinical studies to specialized Contract Research Organizations. This trend is further reinforced by stringent regulatory requirements from authorities such as the FDA Center for Veterinary Medicine and the USDA Center for Veterinary Biologics, which, adhering to VICH GCP guidelines, mandate rigorous safety and efficacy testing for all novel veterinary products prior to market authorization.

Regional Insights

North America leads the Global Veterinary CRO Market due to a confluence of factors establishing a robust environment for animal health innovation. The region benefits from a well-developed animal healthcare infrastructure and high rates of pet ownership, which consistently drives demand for advanced veterinary products and services. Furthermore, North America hosts a significant concentration of major pharmaceutical and biotechnology companies that actively invest in extensive research and development for animal health solutions. This is supported by advanced R&D capabilities and a favorable, established regulatory framework, notably enforced by the U. S. Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) for animal drugs, which facilitates systematic clinical trial approvals.

Recent Developments

In October 2025, ImpriMed expanded its laboratory facilities and scaled its Contract Research Organization (CRO) services for pharmaceutical partners. The company, which processes canine live cancer cell samples, is now preparing for CLIA certification while increasing its offerings. These expanded CRO services include preclinical drug candidate screening on patient live cells, profiling of responder patient groups, and identifying synergistic drug combinations. This move demonstrates the company's commitment to advancing veterinary oncology research through enhanced laboratory capabilities and specialized CRO offerings within the global market.

In January 2025, Argenta, an animal health pharmaceutical services company, announced a strategic realignment of its Contract Research Organization (CRO) platform. This restructuring was designed to enhance the company's customer value proposition by improving its capabilities to deliver comprehensive, end-to-end research and development (R&D) and product development services within the animal health industry. The realigned CRO platform now includes regulatory, pre-clinical, and clinical CRO services, aiming to integrate various operations and better serve the accelerating needs for specialized services.

In October 2024, Clinglobal completed the acquisition of OCRvet, a European Contract Research Organization (CRO) that specializes in translational and animal health field trials. This strategic acquisition significantly strengthened Clinglobal's presence in the European market. OCRvet's expertise in conducting veterinary clinical trials for new animal health products and its involvement in R&D projects for the pharmaceutical sector contribute to the expanding capabilities of the global veterinary CRO market by adding specialized services for preclinical studies and field trials.

In June 2024, Charles River Laboratories collaborated with Sanofi on a new initiative to incorporate virtual control animals into preclinical research. This project aims to replace live animals in control groups by leveraging extensive historical data, machine learning, and toxicology expertise. The collaboration is part of Charles River's broader Alternative Methods Advancement Project, a multi-year program dedicated to exploring alternatives to traditional animal testing methods. This innovative approach seeks to reduce the number of animals used in studies, impacting the methodology and efficiency of preclinical veterinary CRO services.

Key Market Players

Charles River Laboratories, Inc
Clinvet International Pty Ltd.
Klifovet AG
Lohlein & Wolf Vet Research LLC
Oncovet Clinical Research
ONDAX Incorporation
Triveritas Group LLC.
Veterinary Research Management (VRM) Ltd
Vet Pharm, Inc.
Vetspen Srl.

By Service Type	By Animal Type	By Application	By Region
Clinical Trials Toxicology Market Authorization & Regulatory Support Others	Dogs Cats Others	Oncology Infectious Diseases Cardiovascular Diseases Metabolic Disease Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Veterinary CRO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO Market, By Service Type:

o Clinical Trials

o Toxicology

o Market Authorization & Regulatory Support

o Others

Veterinary CRO Market, By Animal Type:

o Dogs

o Cats

o Others

Veterinary CRO Market, By Application:

o Oncology

o Infectious Diseases

o Cardiovascular Diseases

o Metabolic Disease

o Others

Veterinary CRO Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary CRO Market.

Available Customizations:

Global Veterinary CRO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Veterinary CRO Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary CRO Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support, Others)

5.2.2. By Animal Type (Dogs, Cats, Others)

5.2.3. By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Metabolic Disease, Others)

5.2.4. By Region

5.2.5. By Company (2024)

5.3. Market Map

6. North America Veterinary CRO Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Service Type

6.2.2. By Animal Type

6.2.3. By Application

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Veterinary CRO Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Service Type

6.3.1.2.2. By Animal Type

6.3.1.2.3. By Application

6.3.2. Canada Veterinary CRO Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Service Type

6.3.2.2.2. By Animal Type

6.3.2.2.3. By Application

6.3.3. Mexico Veterinary CRO Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Service Type

6.3.3.2.2. By Animal Type

6.3.3.2.3. By Application

7. Europe Veterinary CRO Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Service Type

7.2.2. By Animal Type

7.2.3. By Application

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Veterinary CRO Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Service Type

7.3.1.2.2. By Animal Type

7.3.1.2.3. By Application

7.3.2. France Veterinary CRO Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Service Type

7.3.2.2.2. By Animal Type

7.3.2.2.3. By Application

7.3.3. United Kingdom Veterinary CRO Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Service Type

7.3.3.2.2. By Animal Type

7.3.3.2.3. By Application

7.3.4. Italy Veterinary CRO Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Service Type

7.3.4.2.2. By Animal Type

7.3.4.2.3. By Application

7.3.5. Spain Veterinary CRO Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Service Type

7.3.5.2.2. By Animal Type

7.3.5.2.3. By Application

8. Asia Pacific Veterinary CRO Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Service Type

8.2.2. By Animal Type

8.2.3. By Application

8.2.4. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Veterinary CRO Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Service Type

8.3.1.2.2. By Animal Type

8.3.1.2.3. By Application

8.3.2. India Veterinary CRO Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Service Type

8.3.2.2.2. By Animal Type

8.3.2.2.3. By Application

8.3.3. Japan Veterinary CRO Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Service Type

8.3.3.2.2. By Animal Type

8.3.3.2.3. By Application

8.3.4. South Korea Veterinary CRO Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Service Type

8.3.4.2.2. By Animal Type

8.3.4.2.3. By Application

8.3.5. Australia Veterinary CRO Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Service Type

8.3.5.2.2. By Animal Type

8.3.5.2.3. By Application

9. Middle East & Africa Veterinary CRO Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Service Type

9.2.2. By Animal Type

9.2.3. By Application

9.2.4. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Veterinary CRO Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Service Type

9.3.1.2.2. By Animal Type

9.3.1.2.3. By Application

9.3.2. UAE Veterinary CRO Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Service Type

9.3.2.2.2. By Animal Type

9.3.2.2.3. By Application

9.3.3. South Africa Veterinary CRO Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Service Type

9.3.3.2.2. By Animal Type

9.3.3.2.3. By Application

10. South America Veterinary CRO Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Service Type

10.2.2. By Animal Type

10.2.3. By Application

10.2.4. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Veterinary CRO Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Service Type

10.3.1.2.2. By Animal Type

10.3.1.2.3. By Application

10.3.2. Colombia Veterinary CRO Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Service Type

10.3.2.2.2. By Animal Type

10.3.2.2.3. By Application

10.3.3. Argentina Veterinary CRO Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Service Type

10.3.3.2.2. By Animal Type

10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Veterinary CRO Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Charles River Laboratories, Inc

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Clinvet International Pty Ltd.

15.3. Klifovet AG

15.4. Lohlein & Wolf Vet Research LLC

15.5. Oncovet Clinical Research

15.6. ONDAX Incorporation

15.7. Triveritas Group LLC.

15.8. Veterinary Research Management (VRM) Ltd

15.9. Vet Pharm, Inc.

15.10. Vetspen Srl.

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Veterinary CRO Market in 2024?

Which is the dominating region in the Global Veterinary CRO Market?

Which is the fastest growing segment in the Global Veterinary CRO Market?

What is the expected growth rate of the Global Veterinary CRO Market?